logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

LARC: neoadjuvant mFOLFOX6 found safe in multicenter study

N stage downgraded in >50% of patients with locally advanced rectal cancer.